Compounded GLP-1 for Sale: A Buyer's Guide to Doing It Right
By GLP-1 Evolution Research Team | Last updated: May 18, 2026
TL;DR
- Compounded GLP-1 = semaglutide or tirzepatide prepared by a 503A (patient-specific) or 503B (outsourcing facility) compounding pharmacy.
- Legal when dispensed by a licensed pharmacy under a valid prescription. Not legal as "research peptides" for human use.
- Cost: $129-$349/month vs $1,000+ for branded.
- Safety depends on the pharmacy: named partner, USP-grade API, FDA-inspected facility.
- After the FDA shortage list change, 503A patient-specific compounding can continue for clinical reasons; 503B status depends on shortage designation.
What "Compounded" Actually Means
Pharmacy compounding is the practice of preparing a personalized medication for an individual patient. It's been part of US healthcare for over a century. The two regulatory frameworks relevant in 2026:
- 503A pharmacies compound for individual patients based on a specific prescription. Regulated primarily by state boards of pharmacy with FDA oversight.
- 503B outsourcing facilities can compound in larger batches without patient-specific prescriptions, but must register with the FDA and comply with cGMP standards similar to manufacturers.
Compounded GLP-1s come from both lanes depending on the program. The molecule (semaglutide or tirzepatide) is the same as branded; the manufacturing pathway and regulatory framework differ.
Legal Status in 2026
When Eli Lilly's tirzepatide and Novo Nordisk's semaglutide were on the FDA drug shortage list, 503B outsourcing facilities could legally compound copies in bulk. As shortage status has shifted, the legal basis for 503B copies has tightened. 503A patient-specific compounding remains available when there's a documented clinical reason (allergy to inactive ingredients, need for customized dose, etc.).
The legal landscape is fluid. Reputable telehealth programs adjust their sourcing as FDA guidance changes. If a program won't explain its current legal basis or name its pharmacy, that's a warning sign.
How to Verify a Compounded GLP-1 Program
- Named pharmacy partner. The program should disclose the dispensing pharmacy. Look it up on your state board of pharmacy license database or the FDA's 503B registered outsourcing facility list.
- USP-grade active ingredient. The pharmacy should be sourcing pharmaceutical-grade semaglutide or tirzepatide, ideally with a Certificate of Analysis available on request.
- Clinical intake. A real medical evaluation, not a checkbox form.
- US-based. Both the prescriber and the pharmacy must be licensed in the US, in your state where required.
- Cold-chain shipping. The medication must arrive cold, with packaging that maintained the temperature in transit.
What to Avoid
The "research peptide" market sells unregulated semaglutide and tirzepatide products labeled "not for human use" through websites that don't require a prescription. These products:
- Are not made under FDA-inspected conditions.
- May contain incorrect concentrations or contaminants.
- Carry no clinical oversight if you develop side effects.
- Place the buyer in a legally gray (often illegal) position for human administration.
The price savings vs a legitimate compounded program ($149-$199/month) are not worth the risk. See our compounded GLP-1 myths debunked for more.
Cost Comparison
| Source | Monthly Cost | Regulatory Status |
|---|---|---|
| Branded retail (Zepbound, Wegovy) | $1,000-$1,400 | FDA-approved |
| Lilly Direct vials | ~$500-$700 | FDA-approved, manufacturer cash-pay |
| Compounded telehealth (vetted) | $129-$349 | 503A/503B |
| Research peptide vendors | $50-$150 | Not legal for human use |
Five Programs We Track
Embody at $149/month remains our entry-tier pick. Eden Health at $209 flat-rate offers no-escalation pricing. SHED at $199-$299 bundles supplements and coaching with a 10% money-back offer (marketing claim by SHED; individual results vary based on diet, exercise, medical history, and adherence). SkinnyRx at $179 first month is the cheapest starter. See our complete provider review.
Clinical Evidence Recap
Compounded semaglutide and tirzepatide deliver the same active molecule studied in the STEP-1 (PMID 33567185) and SURMOUNT-1 (PMID 35658024) trials. Pharmacokinetic equivalence to branded products has not been independently studied at scale for every compounding pharmacy, which is one reason pharmacy quality matters.
Frequently Asked Questions
What is compounded GLP-1?
Semaglutide or tirzepatide prepared by a 503A/503B pharmacy.
Is it legal?
Yes via a licensed pharmacy and valid prescription.
Is it safe?
Yes when the pharmacy is vetted and the program names its partner.
Cost?
$129-$349/month vs $1,000+ branded.
Why cheaper?
No branded distribution markup.